Sort
15,842 grants matching “pancreatic cancer”
Molecular Mechanism of Orlistat Hydrolysis by FASN for Targeted Drug Discovery
$30,882Valerie Elizabeth Fako · Indiana University Indianapolis · F31 · FY2012 · CA
Novel Biodegradable Nanoadjuvants for Immunotherapy of Pancreatic Cancer
$30,834Maria P Torres-Gonzalez · Iowa State University · F31 · FY2006 · CA
POST TRANSLATIONAL MODIFICATIONS & PARTNERS OF P8, A TUMORIGENIC PROTEIN
$30,820Silvia N Moreno · University Of California, San Francisco · P41 · FY2007 · RR
Disease Initation and the role of DCs in the TRUC Model of ulcerative colitis
$30,820Wendy S. Garrett · Harvard School Of Public Health · K08 · FY2009 · AI
Defining PI3K p110alpha as a therapeutic target in pancreatic cancer
$30,793Eileen S Carpenter · State University New York Stony Brook · F30 · FY2012 · CA
Defining PI3K p110alpha as a therapeutic target in pancreatic cancer
$30,793Eileen S Carpenter · State University New York Stony Brook · F30 · FY2013 · CA
Illness Perception, Pain, and Symptom Distress in Gastrointestinal Cancers
$30,773Virginia Chih-Yi Sun · University Of California Los Angeles · F31 · FY2008 · NR
The role of Neuropilin 1 in Glioma Associated Microglia and Macrophages
$30,752Jeremy Tetsuo Miyauchi · State University New York Stony Brook · F30 · FY2019 · CA
PRSS1 Mutation and Pancreatic Cancer Tumorigenesis
$30,693Baoan Ji · Mayo Clinic Jacksonville · R01 · FY2023 · CA
High throughput screens for fatty acid uptake inhibitors
$30,619Concetta C. Dirusso · Ordway Research Institute, Inc. · R01 · FY2007 · DK
K-Ras mutant-specific vulnerabilities for novel pancreatic cancer therapies
$30,587Guy Aaron Hobbs · Univ Of North Carolina Chapel Hill · F32 · FY2018 · CA
FOLFOX-induced kinome reprogramming in pancreatic cancer tumor xenografts
$30,558Matthew Lipner · Univ Of North Carolina Chapel Hill · F30 · FY2018 · CA
Acetaldehyde and Epithelial Junctions: Role of PP2A and Occludin Phosphorylation
$30,509Mitzi Lee Dunagan · University Of Tennessee Health Sci Ctr · F31 · FY2010 · AA
Defining the Role and Mechanism of Pak1 in Supporting Pancreatic Cancer
$30,501Nicole Marie Baker · Univ Of North Carolina Chapel Hill · F31 · FY2014 · CA
MINORITY PREDOCTORAL FELLOWSHIP PROGRAM
$30,469Mark W Schramp · University Of California Berkeley · F31 · FY2008 · CA
SysCODE: PMAGE Technology Development (10 of 10)
$30,407Jonathan G Seidman · Harvard Medical School · PL1 · FY2009 · HL
The Role of Oncostatin M in the PDAC tumor microenvironment and macroenvironment
$30,306Daenique Jengelley · Indiana University Indianapolis · F31 · FY2021 · CA
Acetaldehyde and Epithelial Junctions: Role of PP2A and Occludin Phosphorylation
$30,305Mitzi Lee Dunagan · University Of Tennessee Health Sci Ctr · F31 · FY2009 · AA
Genomic Landscape of Pancreatic Cancer Metastasis
$30,128David Balli · University Of Pennsylvania · F32 · FY2015 · CA
FOLFOX-induced kinome reprogramming in pancreatic cancer tumor xenografts
$30,078Matthew Lipner · Univ Of North Carolina Chapel Hill · F30 · FY2017 · CA
Comprehensive modeling of tumor suppressor gene-derived neoantigens in pancreatic cancer
$30,058Zackery Ely · Massachusetts Institute Of Technology · F31 · FY2022 · CA
SPARC as a regulator of collagen signaling in Pancreatic Cancer
$30,041Kristina Yolanda Aguilera · Ut Southwestern Medical Center · F31 · FY2014 · CA
Program 3: Free Radical Metabolism and Imaging
$30,038Douglas Robert Spitz · University Of Iowa · P30 · FY2019 · CA
Program 3: Free Radical Metabolism and Imaging
$30,037Douglas Robert Spitz · University Of Iowa · P30 · FY2020 · CA
Africa Hepatopancreatobiliary Cancer Consortium
$30,000Lewis R Roberts · Mayo Clinic Rochester · R13 · FY2022 · CA